News/Reuters/Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For ToripalimabShanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For ToripalimabRefinitivStart a free trial to read this news30-day free trial
